PREVALANCE OF HEPATITIS B AND HEPATATIS C AMONG HEALTHY BLOOD DONORS AT KURRAM AGENCY
Main Article Content
Abstract
Objective: To find sero-prevalance of HBSAg and HCV antibody among healthy donors of Kurram Agency, FATA, Pakistan
Material and Methods: The study design was cross-sectional. Data was collected from blood transfusion units, Pathology departments, blood donor units at Parachinar and Sadda to know the frequency of Hepatitis B and Hepatitis C in healthy blood donors. For blood donations non professional blood donor were selected. Questions regarding frequent blood donation, surgical procedure in past and other risk factors about hepatitis B and C transmission were asked. Screening for HBsAg, and HCV antibodies was done by using rapid immunochromatography kits.
Results: A total of thirteen hundred healthy donors were received during a period of one year. The seroprevalence of various infectious markers was as follows; Out of the total 1300, 66(5.07%) donors were found to be positive for Hepatitis B surface antigen HBsAg and 15(1.1%) were found positive for HCV antibody. Six donors were positive for both HBsAg and Anti HCV antibody.
Conclusion: It is concluded that HCV and HBV has become major problems in FATA like rest of the country and screening for not only blood donation but also in general should be done to prevent the disease escalation. Due to the high cost of treatment of hepatitis B and C virus infection and the unavailability of a vaccine against HCV, the main focus should be on preventive aspects. Here comes the
importance of identifying the genotype of the virus infecting a person, which is not a common practice in Pakistan. Mostly treatment is given without knowing the genotype, which may result in no response or emergence of mutant strains of the virus.
Article Details
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.